Genome wide methylation profiling of selected matched soft tissue sarcomas identifies methylation changes in metastatic and recurrent disease

[1]  M. Belli,et al.  Ionizing Radiation-Induced Epigenetic Modifications and Their Relevance to Radiation Protection , 2020, International journal of molecular sciences.

[2]  Kevin B. Jones,et al.  The epigenomics of sarcoma , 2020, Nature Reviews Cancer.

[3]  Chao Zhang,et al.  The Potential of Five Immune-Related Prognostic Genes to Predict Survival and Response to Immune Checkpoint Inhibitors for Soft Tissue Sarcomas Based on Multi-Omic Study , 2020, Frontiers in Oncology.

[4]  M. Tartaglia,et al.  DNA Methylation Profiling for Diagnosing Undifferentiated Sarcoma with Capicua Transcriptional Receptor (CIC) Alterations , 2020, International journal of molecular sciences.

[5]  W. V. Graham,et al.  Contributions of Myosin Light Chain Kinase to Regulation of Epithelial Paracellular Permeability and Mucosal Homeostasis , 2020, International journal of molecular sciences.

[6]  A. Talhouk,et al.  DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics , 2019, Journal of cancer research and clinical oncology.

[7]  Yunbing Wang,et al.  Systematic screening identifies a 2‐gene signature as a high‐potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcoma , 2019, Journal of cellular and molecular medicine.

[8]  Xinling Wang,et al.  LncRNA WT1-AS up-regulates p53 to inhibit the proliferation of cervical squamous carcinoma cells , 2019, BMC Cancer.

[9]  Xuan Yang,et al.  LncRNA WT1-AS Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Downregulating Transforming Growth Factor β1. , 2019, Cancer biotherapy & radiopharmaceuticals.

[10]  Y. Hoshino,et al.  Conservative treatment for stable low-energy thoracolumbar vertebral fractures in nonfused segments among elderly patients with diffuse idiopathic skeletal hyperostosis , 2019, Medicine.

[11]  Shan Kang,et al.  Genome‐wide analysis of DNA methylation in endometriosis using Illumina Human Methylation 450 K BeadChips , 2019, Molecular reproduction and development.

[12]  Jiaxin Liu,et al.  Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools , 2019, BMC Cancer.

[13]  Wei Wang,et al.  Integrative analysis with expanded DNA methylation data reveals common key regulators and pathways in cancers , 2018, npj Genomic Medicine.

[14]  P. Vahteristo,et al.  Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas , 2018, Cancer.

[15]  Jing Yang,et al.  Expression of long non-coding RNA and mRNA in the hippocampus of mice with type 2 diabetes , 2018, Molecular medicine reports.

[16]  Yang Zhang,et al.  Methylation and Expression of Nonclustered Protocadherins Encoding Genes and Risk of Precancerous Gastric Lesions in a High-Risk Population , 2018, Cancer Prevention Research.

[17]  A. Isaksson,et al.  Different patterns of clonal evolution among different sarcoma subtypes followed for up to 25 years , 2018, Nature Communications.

[18]  P. Schofield,et al.  Evolving paradigms for the biological response to low dose ionizing radiation; the role of epigenetics , 2018, International journal of radiation biology.

[19]  Sakae Tanaka,et al.  Integrated genetic and epigenetic analysis of myxofibrosarcoma , 2018, Nature Communications.

[20]  C. Sarkar,et al.  Identification of miR-379/miR-656 (C14MC) cluster downregulation and associated epigenetic and transcription regulatory mechanism in oligodendrogliomas , 2018, Journal of Neuro-Oncology.

[21]  Hong Gao,et al.  The homeobox protein VentX reverts immune suppression in the tumor microenvironment , 2018, Nature Communications.

[22]  J. Tanner,et al.  The Proline Cycle As a Potential Cancer Therapy Target. , 2018, Biochemistry.

[23]  David T. W. Jones,et al.  Array-based DNA-methylation profiling in sarcomas with small blue round cell histology provides valuable diagnostic information , 2018, Modern Pathology.

[24]  M. Snuderl,et al.  Abstract PR01: A DNA methylation-based classifier for accurate molecular diagnosis of bone sarcomas , 2018 .

[25]  B. V. Van Tine,et al.  Synovial Sarcoma: Current Concepts and Future Perspectives. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  J. Hornick,et al.  Contemporary Sarcoma Diagnosis, Genetics, and Genomics. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  Steven J. M. Jones,et al.  Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas , 2017, Cell.

[28]  Yukio Nakatani,et al.  Frequent promoter hypermethylation associated with human papillomavirus infection in pharyngeal cancer. , 2017, Cancer letters.

[29]  Jingru Zhang,et al.  Identification of potentially critical differentially methylated genes in nasopharyngeal carcinoma: A comprehensive analysis of methylation profiling and gene expression profiling , 2017, Oncology letters.

[30]  S. Beck,et al.  Validation of the MethylationEPIC BeadChip for fresh-frozen and formalin-fixed paraffin-embedded tumours , 2017, Clinical Epigenetics.

[31]  I. Koturbash,et al.  Effects of ionizing radiation on DNA methylation: from experimental biology to clinical applications , 2017, International journal of radiation biology.

[32]  E. Raymond,et al.  Novel TGF-β inhibitors ready for prime time in onco-immunology , 2016, Oncoimmunology.

[33]  B. Moser,et al.  Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets , 2016, Pathology & Oncology Research.

[34]  P. Malfertheiner,et al.  Leukotriene receptor expression in esophageal squamous cell cancer and non-transformed esophageal epithelium: a matched case control study , 2016, BMC Gastroenterology.

[35]  Ping Zheng,et al.  Decreased expression of long non-coding RNA WT1-AS promotes cell proliferation and invasion in gastric cancer. , 2016, Biochimica et biophysica acta.

[36]  K. Okamura,et al.  Genomic, Epigenomic, and Transcriptomic Profiling towards Identifying Omics Features and Specific Biomarkers That Distinguish Uterine Leiomyosarcoma and Leiomyoma at Molecular Levels , 2015, Sarcoma.

[37]  Y. Jeng,et al.  Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas , 2015, Modern Pathology.

[38]  S. Tavazoie,et al.  PTPRN2 and PLCβ1 promote metastatic breast cancer cell migration through PI(4,5)P2‐dependent actin remodeling , 2015, The EMBO journal.

[39]  Jun Li,et al.  WT1-AS promotes cell apoptosis in hepatocellular carcinoma through down-regulating of WT1 , 2015, Journal of experimental & clinical cancer research : CR.

[40]  Feng-Chi Chen,et al.  Triple-layer dissection of the lung adenocarcinoma transcriptome – regulation at the gene, transcript, and exon levels , 2015, Oncotarget.

[41]  L. van Neste,et al.  Formalin-fixed, paraffin-embedded (FFPE) tissue epigenomics using Infinium HumanMethylation450 BeadChip assays , 2015, Laboratory Investigation.

[42]  Tania L. Slatter,et al.  Loss of ATRX and DAXX expression identifies poor prognosis for smooth muscle tumours of uncertain malignant potential and early stage uterine leiomyosarcoma , 2015, The journal of pathology. Clinical research.

[43]  Y. Jeng,et al.  Leiomyosarcoma With Alternative Lengthening of Telomeres Is Associated With Aggressive Histologic Features, Loss of ATRX Expression, and Poor Clinical Outcome , 2015, The American journal of surgical pathology.

[44]  Raphael Gottardo,et al.  Orchestrating high-throughput genomic analysis with Bioconductor , 2015, Nature Methods.

[45]  M. Chiquet,et al.  Transcriptional regulation of tenascin genes , 2015, Cell adhesion & migration.

[46]  S. Eschrich,et al.  Expanding Epigenomics to Archived FFPE Tissues: An Evaluation of DNA Repair Methodologies , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[47]  Ying Zhou,et al.  Expression of undifferentiated embryonic cell transcription factor-1 (UTF1) in breast cancers and their matched normal tissues , 2014, Cancer Cell International.

[48]  L. Looijenga,et al.  DMRforPairs: identifying Differentially Methylated Regions between unique samples using array based methylation profiles , 2014, BMC Bioinformatics.

[49]  C. Cluzel,et al.  Tenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-β , 2014, The Journal of cell biology.

[50]  Wenjun Zhang,et al.  Liver X receptor activation induces apoptosis of melanoma cell through caspase pathway , 2014, Cancer Cell International.

[51]  J. Bridge,et al.  Pharmacologic inhibition of epigenetic modification reveals targets of aberrant promoter methylation in ewing sarcoma , 2013, Pediatric blood & cancer.

[52]  J. Lutterbaugh,et al.  NTRK3 Is a Potential Tumor Suppressor Gene Commonly Inactivated by Epigenetic Mechanisms in Colorectal Cancer , 2013, PLoS genetics.

[53]  Wei Kang,et al.  Genome‐wide identification of Epstein‐Barr virus–driven promoter methylation profiles of human genes in gastric cancer cells , 2013, Cancer.

[54]  R. Eils,et al.  MicroRNA profiling of primary high‐grade soft tissue sarcomas , 2012, Genes, chromosomes & cancer.

[55]  P. Delvenne,et al.  Aberrant Promoter Methylation and Expression of UTF1 during Cervical Carcinogenesis , 2012, PloS one.

[56]  M. Khurshid,et al.  Analysis of molecular cytogenetic alterations in uterine leiomyosarcoma by array-based comparative genomic hybridization , 2012, Journal of Cancer Research and Clinical Oncology.

[57]  I. Bennani-Baiti.  Epigenetic and epigenomic mechanisms shape sarcoma and other mesenchymal tumor pathogenesis. , 2011, Epigenomics.

[58]  F. Motoi,et al.  Identification of epigenetically silenced genes in human pancreatic cancer by a novel method "microarray coupled with methyl-CpG targeted transcriptional activation" (MeTA-array). , 2011, Biochemical and biophysical research communications.

[59]  Xiao Zhang,et al.  Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis , 2010, BMC Bioinformatics.

[60]  Andrew E. Teschendorff,et al.  Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue using the Illumina Infinium HumanMethylation27 BeadChip. , 2010, Methods.

[61]  Y. Kim,et al.  Identification of differentially expressed genes using an annealing control primer system in stage III serous ovarian carcinoma , 2010, BMC Cancer.

[62]  A. Feinberg,et al.  Comprehensive High‐Throughput Arrays for Relative Methylation (CHARM) , 2010, Current protocols in human genetics.

[63]  J. Hescheler,et al.  Initial Colony Morphology-Based Selection for iPS Cells Derived from Adult Fibroblasts Is Substantially Improved by Temporary UTF1-Based Selection , 2010, PloS one.

[64]  P. Laird.  Principles and challenges of genome-wide DNA methylation analysis , 2010, Nature Reviews Genetics.

[65]  Yuan Yuan,et al.  Tenascin-X is a Novel Diagnostic Marker of Malignant Mesothelioma , 2009, The American journal of surgical pathology.

[66]  Gang Meng,et al.  Changes in genomic imprinting and gene expression associated with transformation in a model of human osteosarcoma. , 2008, Experimental and molecular pathology.

[67]  Rafael A Irizarry,et al.  Comprehensive high-throughput arrays for relative methylation (CHARM). , 2008, Genome research.

[68]  Li Zhang,et al.  Genome-Wide Profiling of DNA Methylation Reveals a Class of Normally Methylated CpG Island Promoters , 2007, PLoS genetics.

[69]  S. Hirohashi,et al.  Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers. , 2006, Cancer research.

[70]  M. Debiec‐Rychter,et al.  Local recurrence of myxofibrosarcoma is associated with increase in tumour grade and cytogenetic aberrations, suggesting a multistep tumour progression model , 2006, Modern Pathology.

[71]  Mukesh Verma,et al.  WT1 and WT1‐AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma , 2005, Cancer.

[72]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.

[73]  M. Esteller.  CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future , 2002, Oncogene.

[74]  Scar,et al.  Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. , 2000, The New England journal of medicine.

[75]  J. Herman,et al.  Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. , 1999, Cancer research.

[76]  L. Mabonga,et al.  The oncogenic potential of small nuclear ribonucleoprotein polypeptide G: a comprehensive and perspective view. , 2019, American journal of translational research.

[77]  Xiao-bin Cui,et al.  Transforming growth factor-β1 signaling promotes epithelial-mesenchymal transition-like phenomena, cell motility, and cell invasion in synovial sarcoma cells , 2017, PloS one.

[78]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[79]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[80]  M Kanehisa,et al.  Organizing and computing metabolic pathway data in terms of binary relations. , 1997, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.